Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice-Reference-Cited by-同舟云学术

Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice

Published:2011-05 Issue:5 Volume:140 Page:1642-1652
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Popov Yury,Sverdlov Deanna Y.,Sharma Anisha K.,Bhaskar K. Ramakrishnan,Li Shaoyong,Freitag Tobias L.,Lee James,Dieterich Walburga,Melino Gerry,Schuppan Detlef

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Liver cirrhosis;Schuppan;Lancet,2008

2. Mechanisms of hepatic fibrogenesis;Friedman;Gastroenterology,2008

3. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies;Popov;Hepatology,2009

4. Matrix as a modulator of hepatic fibrogenesis;Schuppan;Semin Liver Dis,2001

5. Lysyl oxidase: an oxidative enzyme and effector of cell function;Lucero;Cell Mol Life Sci,2006

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unique metabolomics characteristics for distinguishing cirrhosis related to different liver diseases: A systematic review and meta-analysis;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-06

2. Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling;Materials Today Bio;2024-04

3. Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal;Hepatology Communications;2024-03-11

4. ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer;Hepatology;2024-02-20

5. Novel insights into metabolic‐associated steatotic liver disease preclinical models;Liver International;2024-01-30